Florian Gothe

2.1k total citations
16 papers, 286 citations indexed

About

Florian Gothe is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Infectious Diseases. According to data from OpenAlex, Florian Gothe has authored 16 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Florian Gothe's work include Immunodeficiency and Autoimmune Disorders (5 papers), Cystic Fibrosis Research Advances (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Florian Gothe is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Cystic Fibrosis Research Advances (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Florian Gothe collaborates with scholars based in Germany, United Kingdom and Sweden. Florian Gothe's co-authors include Florian Beigel, Sibylle Koletzko, Sophie Hambleton, Dag Aarsland, Daniela Enache, Matthias Kappler, Lars‐Olof Wahlund, Johan Lökk, Matthias Griese and Bengt Winblad and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Florian Gothe

14 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Gothe Germany 11 86 75 48 47 45 16 286
Eirini Apostolou Greece 9 44 0.5× 55 0.7× 49 1.0× 30 0.6× 36 0.8× 22 289
Rasoul Nasiri Kalmarzi Iran 13 127 1.5× 58 0.8× 45 0.9× 39 0.8× 21 0.5× 46 432
Gavin Spickett United Kingdom 10 94 1.1× 23 0.3× 39 0.8× 19 0.4× 80 1.8× 23 409
Astrid Starke Switzerland 10 110 1.3× 52 0.7× 26 0.5× 11 0.2× 35 0.8× 12 411
Mehmet Halil Çelıksoy Türkiye 10 76 0.9× 51 0.7× 19 0.4× 11 0.2× 37 0.8× 51 287
Ourania D Argyropoulou Greece 9 57 0.7× 52 0.7× 51 1.1× 16 0.3× 57 1.3× 27 288
Michi Kawamoto Japan 11 24 0.3× 35 0.5× 50 1.0× 36 0.8× 33 0.7× 66 383
Catarina Mota Portugal 10 80 0.9× 19 0.3× 23 0.5× 79 1.7× 48 1.1× 22 256
Paul Beech Australia 10 20 0.2× 42 0.6× 64 1.3× 26 0.6× 74 1.6× 23 310
Oscar‐Danilo Ortega‐Hernandez Israel 12 140 1.6× 47 0.6× 63 1.3× 19 0.4× 38 0.8× 16 505

Countries citing papers authored by Florian Gothe

Since Specialization
Citations

This map shows the geographic impact of Florian Gothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Gothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Gothe more than expected).

Fields of papers citing papers by Florian Gothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Gothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Gothe. The network helps show where Florian Gothe may publish in the future.

Co-authorship network of co-authors of Florian Gothe

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Gothe. A scholar is included among the top collaborators of Florian Gothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Gothe. Florian Gothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Röschinger, Wulf, Florian Gothe, Maria Feilcke, et al.. (2024). Single-centre prospective evaluation of the first 5 years of cystic fibrosis newborn screening in Germany. ERJ Open Research. 10(2). 699–2023.
2.
Knoflach, Katrin, Christina Rapp, Nicolaus Schwerk, et al.. (2023). Diffuse alveolar hemorrhage in children with interstitial lung disease: Determine etiologies!. Pediatric Pulmonology. 58(4). 1106–1121. 3 indexed citations
3.
Hanrath, Aidan T., Florian Gothe, Cathy Browne, et al.. (2022). Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia. Frontiers in Immunology. 13. 1035532–1035532. 5 indexed citations
4.
Gothe, Florian, Jarmila Stremenova Spegarova, Helen Griffin, et al.. (2022). Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. Journal of Allergy and Clinical Immunology. 150(4). 955–964.e16. 32 indexed citations
5.
Gothe, Florian, Christina Rapp, Katrin Knoflach, et al.. (2021). Early‐onset, fatal interstitial lung disease in STAT3 gain‐of‐function patients. Pediatric Pulmonology. 56(12). 3934–3941. 10 indexed citations
6.
Gothe, Florian, et al.. (2021). Monogenic susceptibility to live viral vaccines. Current Opinion in Immunology. 72. 167–175. 5 indexed citations
7.
Gans, Melissa, Timothy Ronan Leahy, Florian Gothe, et al.. (2020). JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease. The Journal of Allergy and Clinical Immunology In Practice. 9(2). 1008–1010.e2. 21 indexed citations
8.
Gothe, Florian, et al.. (2020). Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2608–2614.e3. 12 indexed citations
9.
Gothe, Florian, Linh Truong, Veronika Kanderová, et al.. (2020). A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis. Clinical Infectious Diseases. 74(1). 136–139. 17 indexed citations
10.
Gilmour, Kimberly, Florian Gothe, Sam Loughlin, et al.. (2019). Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib. Journal of Clinical Immunology. 39(8). 776–785. 17 indexed citations
11.
Gothe, Florian, Matthias Kappler, & Matthias Griese. (2017). Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis. The Journal of Allergy and Clinical Immunology In Practice. 5(6). 1591–1598.e6. 10 indexed citations
12.
Griese, Matthias, Meike Hengst, Jan Ripper, et al.. (2015). Categorizing diffuse parenchymal lung disease in children. Orphanet Journal of Rare Diseases. 10(1). 122–122. 35 indexed citations
13.
Gothe, Florian, et al.. (2014). Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: Correlation to clinical and laboratory findings. Journal of Crohn s and Colitis. 8(9). 1072–1078. 37 indexed citations
14.
Gothe, Florian, et al.. (2013). Serum 7-Alpha-Hydroxy-4-Cholesten-3-One as a Marker for Bile Acid Loss in Children. The Journal of Pediatrics. 163(5). 1367–1371.e1. 23 indexed citations
15.
Enache, Daniela, Ove Almkvist, Vesna Jelić, et al.. (2013). 1621 – Depressive Symptoms And Cognitive Functioning In Elderly. European Psychiatry. 28(S1).
16.
Gothe, Florian, Daniela Enache, Lars‐Olof Wahlund, et al.. (2012). Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment.. PubMed. 54(3). 161–70. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026